StockVS

Translational Development Acquisition Corp. (TDACU) 股票分析

金融服务

Translational Development Acquisition Corp.

$17.29

+$6.85 (+65.61%)

最后更新: 2026年5月26日

价格走势

相关壳公司股票

XXI

Twenty One Capital, Inc.

$2.49B

 CCCX

Churchill Capital Corp X

$711.00M

 DMII

Drugs Made In America Acquisition II Corp.

$641.46M

 BCSS

Bain Capital GSS Investment Corp.

$595.68M

 EVAC

EQV Ventures Acquisition Corp. II

$594.41M

 CEPF

Cantor Equity Partners IV, Inc.

$591.50M
查看所有壳公司股票 →

金融服务热门股票

BRK.TO

Berkshire Hathaway Inc.

$1.38T

 BRK-B

Berkshire Hathaway Inc.

$1.04T

 BRK-A

Berkshire Hathaway Inc.

$1.04T

 JPM

JPMorgan Chase & Co.

$821.91B

 V

Visa Inc.

$620.88B
查看所有金融服务股票 →

关于Translational Development Acquisition Corp.

Translational Development Acquisition Corp. does not have significant operations. The company intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.

公司简介以英文显示。

访问官网 →

关键指标

市值
N/A
市盈率
N/A
52周最高
$17.29
52周最低
$10.27
平均成交量
133

数据由Yahoo Finance通过yfinance提供。每日更新。

公司信息

行业
壳公司
交易所
NASDAQ
国家
United States